Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795551 | 6687186 | I | 5795551-1 | 20071201 | 20080618 | 20080630 | EXP | PHHY2008GB11760 | NOVARTIS PHARMACEUTICALS CORP. | 70 | YR | F | Y | 20080630 | OT | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795551 | 1010112645 | PS | GLIVEC | 2 | ORAL | 400 MG/DAY | 21588 | ||||
| 5795551 | 1010112646 | C | HORMONE REPLACEMENT THERAPY | 2 | |||||||
| 5795551 | 1010112647 | C | RITALIN | 1 | 5 MG FIVE TIMES PER DAY |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5795551 | 1010112645 | CHRONIC MYELOID LEUKAEMIA |
| 5795551 | 1010112647 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5795551 | DS |
Reactions reported
| Event ID | PT |
|---|---|
| 5795551 | TENDON RUPTURE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5795551 | 1010112645 | 20050501 | |||
| 5795551 | 1010112647 | 20070901 | 20080101 |